Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats

European Journal of Endocrinology

Volumn 141, Issue 5, 1999, Pages 506-511

  Bluher M ^c   Krohn, K ^c   Wallaschofski, H ^c   Braverman, L E ^a   Paschke, R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HASHIMOTO DISEASE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

EID: 0344286181     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410506     Document Type: Article

References (24)

1. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sata H & Ohtaki S. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 1995 20 231-236.
2. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N & Ota Z. Apoptosis in thyroid diseases: a histochemical study. Endocrine Journal 1995 42 193-201.
3. Arscott PL, Knapp J, Rymaszewski M, Bartron JL, Bretz JD, Thompson NW et al. Fas (APO-1, 1CD 95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 1997 138 5019-5027.
4. Giordano C, Stassi C, De Maria R, Todaro M, Richiusa P, Papoff G et al. Potential involvement of Fas and its ligand in the patho-genesis of Hashimoto's thyroiditis. Science 1997 275 960-963.
5. Mitsiades N, Poulaki V, Kotoula V, Mastorakos, G, Tseleni-Balafouta S, Koutras DA et al. Fas/Fas ligand up-regulation and bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism 1998 83 2199-2203.
6. Nagata S & Goldstein P. The Fas death factor. Science 1995 267 1449-1456.
7. Owen-Schaub LB, Yonehara S, Crump WL & Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cellular Immunology 1992 140 197-205.
8. Suda T, Takahashi T, Goldstein P & Nagata S. Molecular cloning expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993 75 1169-1178.
9. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996 137 3163-3169.
10. Stassi G, Todaro M, Richiusa P, Giordano P, Mattina A, Sbriglia MS et al. Expression of apoptosis inducing CD95 (Fas/Apo 1) on human beta-cells (Abstract). Diabetologia 1995 39 (Suppl) A10.
11. Giordano C, Stassi, G, Todaro M, Richiusa P, De Maria M, Giordano M et al. Triggering of Fas (Fas/Apol)-induced apoptosis in human pancreatic beta cells (Abstract). Diabetologia 1996 39 (Suppl 1) A10.
12. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C & Nonaka K. Mouse islet lysis mediated by interleukin 1-induced Fas. Diabetologia 1996 39 1306-1312.
13. Rasmussen AK, Hartoft-Nielsen ML, Stenvang JP, Ravnsbaek J, Buschard U & Feldt-Rasmussen U. Interleukin-1beta suppresses apoptosis in human thyroid cells. Journal of Endocrinological Investigation 1997 20 (Suppl 5) 159.
14. Blüher M, Krohn K, Wallaschofski H, Braverman LE & Paschke R. Cytokine gene expression in autoimmune thyroiditis in BB/W rats. Thyroid (In Press).
15. Rennie DP, McGregor AM, Keast D, Weetman AP, Ford SM, Dieguez C et al. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology 1982 112 326-330.
16. Maciejewski J, Selleri C, Anderson S & Young NS. Fas antigen expression on CD34+ human bone marrow cells is induced by interferon gamma and TNF alpha potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995 85 3183-3190.
17. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y & Fontana A. Anti-Fas/Apo-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. Journal of Clinical Investigation 1994 94 954-964.
18. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV & Rabinovich A. Beta-cell destruction in NOD mice correlates with Fas (CD 95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes 1999 48 21-28.
19. Keane M, Ettenberg S, Lowrey G, Russell E & Lipkowitz S. Fas expression and function in normal and malignant breast cancer cell lines. Cancer Research 1996 56 4791-4798.
20. Kubo K, Matsuzaki Y, Okazaki M, Kato A, Kobayashi N & Okita K. The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma. Liver 1998 18 117-123.
21. Luo KX, Zhu YF, Zhang LX, He HT, Wang XS & Zhang L. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. Journal of Viral Hepatitis 1997 4 303-307.
22. Ito N, Tsujimoto Y & Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology 1993 151 621-627.
23. Tamura M, Kimura H, Koji T, Tominaga T, Ashizawa K, Kiriyama T et al. Role of apoptosis of thyrocytes in a rat model of goitre. A possible involvement of the Fas system. Endocrinology 1998 139 3646-3653.
24. French LE & Tschopp J. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover. Behring Institute Mitteilungen 1996 97 156-160.